| 영문 | anti-inflammatory agent | 한글 | 항염증제, 소염제, 염증약 |
|---|---|---|---|
| 설명 | 국소에 작용하여 염증을 치료하고 방지하는 약. 염증을 가라앉히는 약을 말한다. 조직을 긴축-치밀하게 하여 장액과 점액의 분비를 줄이고, 표면에 있는 작은 혈관에 빈혈을 일으켜 충혈되는 것을 방지함으로써 염증적 병변을 제거하여 모든 증세를 없앤다. 대부분의 수렴제-완화제-진양제가 이에 속한다. 중요한 성분으로는 알루미늄-비스무트-아연-납화합물(병반-페르마톨-아연화-연당 등) 등이 있다. 작용에 따라 항염증진통제와 항염증효소제로 나뉜다. |
||
| 영문 | anti-diuretic hormone; ADH | 한글 | 항이뇨호르몬 |
|---|---|---|---|
| 설명 | 뇌의 바닥에 붙어있는 호르몬을 주로 분비하는 작은 기관인 뇌하수체 후엽에서 분비되는 호르몬으로 콩팥에서 수분의 흡수를 촉진하여 체내에 수분의 양을 늘이는 역할을 한다. 동시에 혈관을 수축시키는 작용이 있어 혈압을 상승시키는 역할도 한다.    |
||
| CCP | cephalin-cholesterol flocculation; ciliocytophthoria; chronic calcifying pancreatitis; community car... |
|---|---|
| CCP-AuD | Certificate of Clinical Competence in Audiology |
| CCP-SLP | Certificate of Clinical Competence in Speech Language Pathology |
| AB, Ab | 1) Anti-body; 항체 2) Anti-Biotics; 항생제 |
| Anti-ENA | Anti-Extractable Nuclear Antigens |
| CCP | Chronic Calcifying Pancreatitis |
|---|---|
| CCP | Chronic cor pulmonale |
| CCP | Complement Control Protein |
| CCP | critical control point |
| CCP | Cytochrome c peroxidase |
| agent, anti-infective | Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. (12 Dec 1998) |
|---|---|
| anti- | <prefix> A prefix meaning against, opposite or opposed to, contrary, or in place of, in relation to symptoms and diseases, curative. Often used in composition in many English words. It is often shortened to ant-; as, antacid, antarctic. Origin: Gr. against, opposite, instead of. Source: Websters Dictionary (20 Jun 2000) |
| anti-allergic agents | Agents that are used to treat allergic reactions. most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (12 Dec 1998) |
| anti-allergic and respiratory system agents | A collective term for drugs used to treat allergic reactions as well as those drugs that produce an effect on the respiratory system. (12 Dec 1998) |
| anti-anxiety agents | Agents that alleviate anxiety, tension, and neurotic symptoms, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anaesthesia adjuvants. Adrenergic beta-antagonists are commonly used in the symptomatic treatment of anxiety but are not included here. Substances with a benzodiazepine ring structure widely used to treat anxiety and neuroses. Drugs in this class also generally have sedative or weak hypnotic properties and may be effective as muscle relaxants, anticonvulsants, and anaesthesia adjuvants. (12 Dec 1998) |
| anti-arrhythmia agents | Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (12 Dec 1998) |
| anti-asthmatic agents | Drugs that are used to treat asthma. (12 Dec 1998) |
| anti-basement membrane antibody | Autoantibodies to renal glomerular basement membrane antigens. (05 Mar 2000) |
| anti-basement membrane glomerulonephritis | Glomerulonephritis resulting from anti-basement membrane antibodies, characterised by smooth linear deposits of IgG and C3 along glomerular capillary walls; includes rapidly progressive glomerulonephritis and glomerulonephritis in Goodpasture's syndrome. (05 Mar 2000) |
| anti-basement membrane nephritis | Glomerulonephritis produced by autologous or heterologous antibodies to the glomerular capillary basement membranes, the latter known as anti-kidney serum nephritis. (05 Mar 2000) |
| anti-black-tongue factor | A precursor of NAD, that is a product of the oxidation of nicotine. (18 Nov 1997) |
| antibodies, anti-idiotypic | Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. (12 Dec 1998) |
| anti-coagulant agents | Medications, like heparin, used as blood-thinners to prevent blood clots and to maintain open blood vesssels. (12 Dec 1998) |
| anti-D immunoglobulin | rHo(D) immune globulin |
| anti-DNAse B | This is a serologic blood test used to detect antibodies against antideoxyribonuclease B (anti-DNAse B), an antigen that is produced by group A streptococci. This test is used to document a previous streptococcal infection in those who are suspected of having post-streptococcal disease (for example acute glomerulonephritis, rheumatic fever). A normal value is a negative assay. In adults this is less than 85 Todd units /ml. In school-age children this is less than 170 Todd units/ml. In pre-schoolers this is less than 60 Todd units/ml. Anywhere from 70 to 80% of people with rheumatic fever or post-streptococcal acute glomerulonephritis will have elevated anti-DNAse B levels. The test is performed on a venipuncture specimen. (27 Sep 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|